These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3345620)

  • 1. The racemic metoprolol H2-antagonist interaction.
    Toon S; Davidson EM; Garstang FM; Batra H; Bowes RJ; Rowland M
    Clin Pharmacol Ther; 1988 Mar; 43(3):283-9. PubMed ID: 3345620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of ranitidine and cimetidine on the pharmacokinetics and pharmacodynamics of warfarin in man.
    Toon S; Hopkins KJ; Garstang FM; Rowland M
    Eur J Clin Pharmacol; 1987; 32(2):165-72. PubMed ID: 3582481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of ranitidine and cimetidine on the pharmacokinetics and pharmacodynamics of metoprolol.
    Chellingsworth MC; Laugher S; Akhlaghi S; Jack DB; Kendall MJ
    Aliment Pharmacol Ther; 1988 Dec; 2(6):521-7. PubMed ID: 2979275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cimetidine and ranitidine on cardiovascular drugs.
    Baciewicz AM; Baciewicz FA
    Am Heart J; 1989 Jul; 118(1):144-54. PubMed ID: 2662728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of two histamine H2-receptor antagonists, cimetidine and ranitidine, on the plasma levels and clinical effect of nifedipine and metoprolol.
    Kirch W; Rämsch K; Janisch HD; Ohnhaus EE
    Arch Toxicol Suppl; 1984; 7():256-9. PubMed ID: 6151387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction between H2-receptor antagonists and beta-adrenoceptor blockers.
    Mutschler E; Spahn H; Kirch W
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):51S-57S. PubMed ID: 6146340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ranitidine on the disposition of metoprolol.
    Kelly JG; Salem SA; Kinney CD; Shanks RG; McDevitt DG
    Br J Clin Pharmacol; 1985 Feb; 19(2):219-24. PubMed ID: 3986080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pharmacokinetic and pharmacodynamic interaction study between nebivolol and the H2-receptor antagonists cimetidine and ranitidine.
    Kamali F; Howes A; Thomas SH; Ford GA; Snoeck E
    Br J Clin Pharmacol; 1997 Feb; 43(2):201-4. PubMed ID: 9131955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of H2 receptor antagonists on the disposition of flurbiprofen enantiomers.
    Small RE; Cox SR; Adams WJ
    J Clin Pharmacol; 1990 Jul; 30(7):660-4. PubMed ID: 2391398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of theophylline clearance by cimetidine but not ranitidine.
    Powell JR; Rogers JF; Wargin WA; Cross RE; Eshelman FN
    Arch Intern Med; 1984 Mar; 144(3):484-6. PubMed ID: 6322709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of concomitant administration of cimetidine and ranitidine on the pharmacokinetics and electrocardiographic effects of terfenadine.
    Honig PK; Wortham DC; Zamani K; Conner DP; Mullin JC; Cantilena LR
    Eur J Clin Pharmacol; 1993; 45(1):41-6. PubMed ID: 8405028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Debrisoquine phenotype and the pharmacokinetics and beta-2 receptor pharmacodynamics of metoprolol and its enantiomers.
    Jonkers RE; Koopmans RP; Portier EJ; van Boxtel CJ
    J Pharmacol Exp Ther; 1991 Mar; 256(3):959-66. PubMed ID: 1848636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the H2-receptor antagonists cimetidine and ranitidine on the pharmacokinetics of nimodipine in healthy volunteers.
    Mück W; Wingender W; Seiberling M; Woelke E; Rämsch KD; Kuhlmann J
    Eur J Clin Pharmacol; 1992; 42(3):325-8. PubMed ID: 1577052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of quinidine, cimetidine, and ketoconazole on the enantioselective pharmacokinetics and metabolism of metoprolol in rats.
    Boralli VB; Coelho EB; Lanchote VL
    Chirality; 2009 Nov; 21(10):886-93. PubMed ID: 19161215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetics and pharmacodynamics of nifedipine at steady state during concomitant administration of cimetidine or high dose ranitidine.
    Khan A; Langley SJ; Mullins FG; Dixon JS; Toon S
    Br J Clin Pharmacol; 1991 Oct; 32(4):519-22. PubMed ID: 1958451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of oral and intravenous mexiletine: lack of effect of cimetidine and ranitidine.
    Brockmeyer NH; Breithaupt H; Ferdinand W; von Hattingberg M; Ohnhaus EE
    Eur J Clin Pharmacol; 1989; 36(4):375-8. PubMed ID: 2737230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of steady-state procainamide with H2-receptor antagonists cimetidine and ranitidine.
    Rodvold KA; Paloucek FP; Jung D; Gallastegui J
    Ther Drug Monit; 1987 Dec; 9(4):378-83. PubMed ID: 2447687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cimetidine and ranitidine on the pharmacokinetics of quinine.
    Wanwimolruk S; Sunbhanich M; Pongmarutai M; Patamasucon P
    Br J Clin Pharmacol; 1986 Sep; 22(3):346-50. PubMed ID: 3768247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accumulation and adverse effects of metoprolol and propranolol after concurrent administration of cimetidine.
    Kirch W; Spahn H; Köhler H; Mutschler E
    Arch Toxicol Suppl; 1983; 6():379-83. PubMed ID: 6578746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers.
    Luzier AB; Killian A; Wilton JH; Wilson MF; Forrest A; Kazierad DJ
    Clin Pharmacol Ther; 1999 Dec; 66(6):594-601. PubMed ID: 10613615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.